抗酸化剤と抗菌剤を備えた肝臓水解剤を用いた菓子の持続可能な製法
Ignė Juknienė1, Naga Pavan Kumar Reddy Jonnagiri1, Irena Mačionienė2
1Department of Food Safety and Quality, Lithuanian University of Health Sciences, Veterinary Academy, Tilzes St. 18, LT-47181 Kaunas, Lithuania.
Microorganisms
|August 28, 2025
まとめ
豚の肝臓タンパク質の水解剤を添加した機能的なガムミーは,抗酸化物質と抗菌剤の性能を高めています. これらの革新的な食品は 消費者に優しい形で 潜在的健康上の利益をもたらします
科学分野:
- 食品科学
- 生物化学
- 微生物学
背景:
- 菓子製品には機能的な成分を配送する人気のあるシステムがあります.
- タンパク質の水解剤は,抗酸化剤と抗菌剤を含む生物活性性を持っています.
- 豚の肝臓は価値あるタンパク質の水解物質の潜在的供給源である.
研究 の 目的:
- 豚の肝臓タンパク質の水解を含んだ機能的なゴムキャンディを開発する.
- これらの水解剤が抗酸化物質と抗菌剤に及ぼす影響を評価する.
- 開発されたガムミーの消費者の受容性と物理化学的特性を評価する.
主な方法:
- ガムマトリックス最適化のための消費者受容性 (OA) テスト.
- ABTS•+とDPPH•アッセイを用いた抗酸化作用の分析
- 主要な病原体 (リステリア,大腸菌,サルモネラ) に対する抗菌効果の評価
- 微生物学的安全性とガムミーの物理化学的特徴
主要な成果:
- 豚の肝臓の水解剤は ガムミーの抗酸化能力を著しく高めました
- サンプルGC5Pa24Ag (パパイン水解,アガール基) は,最も高い抗酸化活性を示した (67. 6 ± 0. 98 μmol/ g ABTS•+, 49. 14 ± 1. 00% DPPH•).
- ペプシンで水解した試料は,L. monocytogenes,E. coli,およびS. Typhimuriumに対する有意な抗菌活性を示した.
- GC5Pa24Agは,最も広い抗菌スペクトルを示し,抑制領域は29. 0 ± 0. 2mmでした.
結論:
- 豚の肝臓タンパク質の水解剤は機能的なゴム菓子に効果的に組み込まれます.
- これらの機能的なゴミは 抗酸化物質と抗菌剤の 顕著な性質を持っています
- 開発された製品は,健康に有益な新しい,消費者フレンドリーなアプローチを提供します.
関連する概念動画
Bioavailability Enhancement: Drug Permeability Enhancement
352
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
352
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
420
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
420
Oral Drug Delivery Systems: Introduction
279
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
279
Oral Drug Delivery Systems: Delayed-Release Systems
222
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
222
Production of Organic Acids
105
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
105


